sponsored byAAAS Golden Fund

EurekAlert!, a service of AAAS
Home About us
Advanced Search
8-Jul-2015 02:39
US Eastern Time




Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books



Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation


Submit a Calendar Item


Links & Resources


RSS Feeds

Accessibility Option On


Portal Home


Background Articles

Research Papers


Links & Resources

Disease in the Developing World

News Releases

Key: Meeting M      Journal J      Funder F

Showing releases 1001-1025 out of 1069.

<< < 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 > >>

Public Release: 10-Sep-2013
Nature Medicine
2 common drugs may help treat deadly Middle East Respiratory Syndrome
Treatment with two common drugs reduced viral replication and lung damage when given to monkeys infected with the virus that causes Middle East Respiratory Syndrome. The condition is a deadly pneumonia that has killed more than 100 people, primarily in the Middle East. The new findings show that a combination of interferon-alpha 2b and ribavirin, drugs routinely used to treat hepatitis C, may be effective against this emerging disease.
NIH/National Institute of Allergy and Infectious Diseases

Contact: Leila Gray
University of Washington

Public Release: 10-Sep-2013
Lancet Infectious Diseases
NIH scientists develop new tests to detect drug-resistant malaria
Researchers have developed two tests that can discern within three days whether the malaria parasites in a given patient will be resistant or susceptible to artemisinin, the key drug used to treat malaria. The tests were developed by researchers from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, working with French and Cambodian colleagues in Cambodia.
NIH/National Institute of Allergy and Infectious Diseases

Contact: Anne A. Oplinger
NIH/National Institute of Allergy and Infectious Diseases

Public Release: 9-Sep-2013
Brown, University of Cape Town team up for HIV social science
Brown University and the University of Cape Town will collaborate under a new NIH grant on social science research and teaching to address HIV.
NIH/National Institute of Child Health and Human Development

Contact: David Orenstein
Brown University

Public Release: 8-Sep-2013
American Chemical Society's 246th National Meeting & Exposition
New 'Heroes of Chemistry' developed products that improve health and protect food supply
The scientists responsible for four inventions that affect the lives of millions of people around the globe will be inducted into the highly prized scientific "Hall of Fame" today as the latest Heroes of Chemistry chosen by the American Chemical Society, the world's largest scientific society.

Contact: Michael Bernstein
American Chemical Society

Public Release: 5-Sep-2013
Wellcome Trust renews support for major overseas program in Malawi
The Malawi-Liverpool-Wellcome Trust Clinical Research Programme -- one of the Wellcome Trust's major overseas programs -- is to receive around £14 million over 5 years in renewed funding, it is announced today.
Wellcome Trust

Contact: Jen Middleton
Wellcome Trust

Public Release: 5-Sep-2013
Agricultural Water Management
UN: Rising reuse of wastewater in forecast but world lacks data on 'massive potential resource'
Amid growing competition for freshwater from industry and cities, coupled with a rising world shortage of potash, nitrogen and phosphorus, an international study predicts a rapid increase in the use of treated wastewater for farming and other purposes worldwide. However, research shows that treated wastewater -- comparable in North America alone to the volume of water flowing over Niagara Falls -- is mostly unused and, in many nations, not even quantified or data is badly outdated.

Contact: Terry Collins
United Nations University

Public Release: 4-Sep-2013
53rd Interscience Conference on Antimicrobial Agents and Chemotherapy
Research highlights from ICAAC meeting
This is selected research from the upcoming 53rd Interscience Conference on Antimicrobial Agents and Chemotherapy. The Conference takes place in Denver, CO from September 10-13, 2013.

Contact: Garth Hogan
American Society for Microbiology

Public Release: 4-Sep-2013
4 institutions from Nepal win the 2013 edition of the António Champalimaud Vision Award
The 2013 António Champalimaud Vision Award recognizes the humanitarian and clinical work of four Non-Governmental Organizations from Nepal. These institutions have fought for a long time against the grave problem of vision disorders in a country where this issue are a social catastrophe.

Contact: Vitor Cunha

Public Release: 4-Sep-2013
Health landscape in 6 global regions reveals rapid progress and daunting challenges
The Institute for Health Metrics and Evaluation and the World Bank have created a series of reports on health in six regions: sub-Saharan Africa, East Asia and Pacific, Eastern Europe and Central Asia, Latin America and the Caribbean, the Middle East and North Africa, and South Asia based on Global Burden of Disease data.

Contact: Rhonda Stewart
Institute for Health Metrics and Evaluation

Public Release: 3-Sep-2013
Journal of the American College of Cardiology
Insulin status is important determinant of weight reduction on vascular function
Researchers from Boston University School of Medicine and Boston Medical Center have found that among obese people who had lost considerable weight, those with high insulin levels -- a marker of insulin resistance in the body -- were the most likely to experience better blood vessel function following the weight loss.

Contact: Gina Orlando
Boston University Medical Center

Public Release: 3-Sep-2013
Effect of iron supplementation among children living in malaria-endemic area on incidence of malaria
Children in a malaria-endemic community in Ghana who received a micronutrient powder with iron did not have an increased incidence of malaria, according to a study in the Sept. 4 issue of JAMA. Previous research has suggested that iron supplementation for children with iron deficiency in malaria-endemic areas may increase the risk of malaria.

Contact: Caitlin McNamee-Lamb
The JAMA Network Journals

Public Release: 2-Sep-2013
Wellcome Trust & KU Leuven announce collaboration with Janssen for dengue drug development
Researchers at the University of Leuven (KU Leuven) are joining forces with Janssen Pharmaceuticals Inc. (Janssen) and the Wellcome Trust to discover and develop candidate antiviral drugs for the prevention and treatment of dengue infection.
Wellcome Trust

Contact: Jen Middleton
Wellcome Trust

Public Release: 2-Sep-2013
Scientists sequence genome of high-value grape, seek secrets of wine's aroma
United Nations University's Venezuela-based BIOLAC programme announces twin biotech breakthroughs, marks 25 years of advancing economic and health interests throughout Latin America and Caribbean.

Contact: Terry Collins
United Nations University

Public Release: 1-Sep-2013
Nature Genetics
Researchers untangle genetics of drug resistant TB
A new method of analyzing whole genome sequences of TB, applied to a massive set of strains of the bacteria collected from clinics around the world, has revealed 39 new genes associated with elevated drug resistance.
Senior Ellison Foundation, Massachusetts General Hospital/Division of Pulmonary and Critical

Contact: David Cameron
Harvard Medical School

Public Release: 1-Sep-2013
Nature Genetics
Mycobacterium tuberculosis: Our African follower for over 70,000 years!
One of the deadliest infectious diseases of humankind emerged in Africa 70,000 years ago, a new genetic analysis of 259 Tuberculosis bacterial strains has shown. According to the study, TB bacteria migrated out of Africa hand-in-hand with the first anatomically modern humans. Today's deadly features of TB may be a result of the common migratory path and changes in human live-styles. These evolutionary findings may impact the future developments of new drugs and vaccines.
MRC UK, Swiss National Science Foundation, National Institutes of Health

Contact: Christian Heuss
Swiss Tropical and Public Health Institute

Public Release: 30-Aug-2013
Scientific Reports
Mosquitoes smell you better at night, study finds
In work published this week in Nature: Scientific Reports, a team of researchers from the University of Notre Dame's Eck Institute for Global Health, led by associate professor Giles Duffield and assistant professor Zain Syed of the Department of Biological Sciences, revealed that the major malaria vector in Africa, the Anopheles gambiae mosquito, is able to smell major human host odorants better at night.

Contact: Giles Duffield
University of Notre Dame

Public Release: 30-Aug-2013
BUSM researchers call for individualized criteria for diagnosing obesity
In a review article, researchers at Boston University School of Medicine discuss the importance of eliminating healthy obese persons from unnecessary pharmaceutical treatments of the disease.

Contact: Gina Orlando
Boston University Medical Center

Public Release: 29-Aug-2013
Proceedings of the Royal Society B
Dueling infections: 1 keeps the other at bay, say UCSB anthropologists
If the idea of hookworms makes you shudder, consider this: Those pesky intestinal parasites may actually help your body ward off other infections, and perhaps even prevent autoimmune and other diseases.

Contact: Andrea Estrada
University of California - Santa Barbara

Public Release: 28-Aug-2013
Cochrane Library
Targeting mosquito breeding sites could boost malaria control efforts in Africa and Asia
A malaria control method that targets mosquito larvae and pupae as they mature in standing water could be an important supplementary measure in the fight against the disease, according to a new report led by the London School of Hygiene & Tropical Medicine.

Contact: Jenny Orton
London School of Hygiene & Tropical Medicine

Public Release: 27-Aug-2013
3 subtypes of gastric cancer suggest different treatment approaches
Stomach cancer, one of the leading causes of cancer death worldwide, actually falls into three broad subtypes that respond differently to currently available therapies, according to researchers at Duke-NUS Graduate Medical School Singapore.
Singapore Agency for Science, Technology and Research

Contact: Sarah Avery
Duke University Medical Center

Public Release: 22-Aug-2013
American Journal of Respiratory and Critical Care Medicine
Study adds lung damage to harmful effects of arsenic
A new study confirms that exposure to low to moderate amounts of arsenic in drinking water can impair lung function. Doses of about 120 parts per billion of arsenic in well water produced lung damage comparable to decades of smoking tobacco. This is the first population-based study to clearly demonstrate significant impairment of lung function, in some cases extensive lung damage, associated with low to moderate arsenic exposure.
National Institutes of Health

Contact: John Easton
University of Chicago Medical Center

Public Release: 22-Aug-2013
New risk model sheds light on arsenic risk in China's groundwater
Arsenic-laden groundwater used for cooking and drinking could pose a risk to the health of almost 20 million people across China. This is shown by a study carried out by Eawag scientists in collaboration with Chinese colleagues and published today in Science. The estimates are based on a risk model incorporating geological and hydrological data, as well as measurements of arsenic in wells. The study is being adopted by the authorities in the national groundwater monitoring program.

Contact: Andri Bryner
Swiss Federal Institute of Aquatic Science and Technology: Eawag

Public Release: 21-Aug-2013
UK Department for International Development commits £ 30 million to DNDi
DFID has announced its renewed support to the Drugs for Neglected Diseases initiative (DNDi), allocating a total of £ 30 million (€ 35 million) over the coming five years (2013-2018) to DNDi's Research & Development portfolio to fight neglected diseases. This grant is part of DFID's larger investment of £ 138 million in nine product development partnerships, including DNDi, for the development of new health tools to address poverty-related diseases.

Contact: Violaine Dällenbach
Drugs for Neglected Diseases Initiative

Public Release: 21-Aug-2013
New England Journal of Medicine
Insecticide-treated bed nets critical to global elimination of filariasis
An international team of scientists have demonstrated that a simple, low-cost intervention holds the potential to eradicate a debilitating tropical disease that threatens nearly 1.4 billion people in more than six dozen countries. The researchers, including Case Western Reserve University School of Medicine professor James Kazura, M.D., found that insecticide-treated bed nets reduce transmission of lymphatic filariasis to undetectable levels -- even in the absence of additional medication.
National Institutes of Health

Contact: Jessica Studeny
Case Western Reserve University

Public Release: 21-Aug-2013
Science Translational Medicine
Experimental Ebola treatment protects some primates even after disease symptoms appear
Scientists have successfully treated the deadly Ebola virus in infected animals following onset of disease symptoms, according to a report published online today in Science Translational Medicine. The results show promise for developing therapies against the virus, which causes hemorrhagic fever with human case fatality rates as high as 90 percent.
Defense Advanced Research Projects Agency, National Institutes of Health, Defense Threat Reduction Agency

Contact: Caree Vander Linden
US Army Medical Research Institute of Infectious Diseases

Showing releases 1001-1025 out of 1069.

<< < 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 > >>